Capecitabine
- Product NDC
- 65162-844
- 11-digit product format
- 651620844
- Labeler code
- 65162
- Product ID
- 65162-844_76650027-01fc-4ee0-beef-7db5513355c4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Capecitabine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA204741
- Marketing category
- ANDA
- Marketing start
- 2017-03-10
- Marketing end
- 2024-02-01
- Substance
- CAPECITABINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-844-06 | 65162084406 | 60 TABLET in 1 BOTTLE (65162-844-06) | 60 tablet | 2017-03-10 | 0000-00-00 | No | No | Current |
| 65162-844-16 | 65162084416 | 120 TABLET in 1 BOTTLE (65162-844-16) | 120 tablet | 2017-03-10 | 0000-00-00 | No | No | Current |
| 65162-844-50 | 65162084450 | 500 TABLET in 1 BOTTLE (65162-844-50) | 500 tablet | 2017-03-10 | 0000-00-00 | No | No | Current |